Duke University Medical Center Dept. of Duke Cancer Center(2) — Durham, North Carolina

Duke University Medical Center Dept. of Duke Cancer Center(2) is a clinical research site located in Durham, North Carolina, United States 27710.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

Duke University Medical Center Dept. of Duke Cancer Center(2) has participated in 1 clinical trials.

Therapeutic areas: Symptomatic Refractory Resistant Carcinoid Disease.

Sponsors: Novartis Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Duke University Medical Center Dept. of Duke Cancer Center(2)?

Duke University Medical Center Dept. of Duke Cancer Center(2) has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Duke University Medical Center Dept. of Duke Cancer Center(2) conducted?

Duke University Medical Center Dept. of Duke Cancer Center(2) has 1 clinical trials on record. Their work covers Symptomatic Refractory Resistant Carcinoid Disease.

Is Duke University Medical Center Dept. of Duke Cancer Center(2) accredited by Crixeo Health?

Duke University Medical Center Dept. of Duke Cancer Center(2) has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Duke University Medical Center Dept. of Duke Cancer Center(2)?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.